CROI 2017 Program and Information

Program and Agenda

518 ESTABLISHING EPIDEMIOLOGICAL LINKAGEWITHINHCV NETWORKS USING GENETIC DISTANCE Rebecca Rose 1 , Susanna Lamers 2 , Guido Massaccesi 3 , William Osburn 3 , Stuart C. Ray 3 , Andrea Cox 3 , Oliver Laeyendecker 4 1 BioInfoExperts, Norfolk, VA, USA, 2 BioInfoExperts, Thibodaux, LA, USA, 3 Johns Hopkins Univ, Baltimore, MD, USA, 4 NIAID, Baltimore, MD, USA 519 HIGH PREVALENCE OF HEPATITIS-C VIRUS AMONGHIV NEGATIVE MSM IN AMSTERDAMPREP PROJECT Elske Hoornenborg 1 , Maria Prins 1 , Roel C.A. Achterbergh 1 , Maarten F. Schim van der Loeff 1 , Udi Davidovich 1 , Arjan Hogewoning 1 , Henry J.C. de Vries 1 , Janke Schinkel 2 , Thijs J.W. van der Laar 3 , for the Amsterdam PrEP Project team in the HIV Transmission Elimination Amsterdam Consortium (H-team) 1 Pub Hlth Service Amsterdam, Amsterdam, Netherlands, 2 Academic Med Cntr, Amsterdam Zuidoost, Netherlands, 3 Stichting Sanquin Bloedvoorziening, Amsterdam, Netherlands 520 HIGH CLUSTERING OF ACUTE HCV INFECTIONS AMONG HIV-POSITIVEMENWHO HAVE SEXWITHMEN Eve Todesco 1 , Nesrine Day 2 , Corinne Amiel 3 , Veronique Schneider 4 , Georges Kreplak 2 , Laurent Roudière 1 , Stéphane Hué 5 , Christine Katlama 1 , Anne-Geneviève Marcelin 1 , Marc-Antoine Valantin 1 1 Pitié-Salpêtrière Hosp, Paris, France, 2 Cerballiance Lab, Paris, France, 3 INSERM, Paris, France, 4 Tenon Hosp, Paris, France, 5 London Sch of Hygiene & Tropical Med, London, UK 521 SYSTEMATIC HCV-RNA SCREEN INHIV+MSMREVEALS HIGH NUMBERS OF POTENTIAL TRANSMITTERS Dominique L. Braun 1 , Roger Kouyos 1 , Benjamin H. Hampel 1 , Christina Grube 1 , Huldrych F. Günthard 1 , Jürg Böni 2 , Jan S. Fehr 1 , for the Swiss HIV Cohort Study 1 Univ Hosp Zurich, Zurich, Switzerland, 2 Univ of Zurich, Zurich, Switzerland THE 2013–2014 DEMOGRAPHIC AND HEALTH SURVEY Gavin Cloherty 1 , Vera Holzmayer 1 , Jacques Pepin 2 , Eric H. Frost 2 , Michael Fried 3 , Anto Tshefu 4 , Franck Fwamba 5 , Jérémie Muwanga 5 , Steven R. Meshnick 3 , Jonathan Parr 3 1 Abbott Labs, Abbott Park, IL, USA, 2 Univ of Sherbrooke, Sherbrooke, Quebec, Canada, 3 Univ of North Carolina at Chapel Hill, Chapel Hill, NC,USA, 4 Univ of Kinshasa, Kinshasa, Democratic Republic of the Congo, 5 Natl AIDS Control Prog (PNLS), Kinshasa, Democratic Republic of the Congo 523 LOWHCV PREVALENCE AMONG HIV+ INDIVIDUALS IN SUB- SAHARAN AFRICA 1 MSF, Epicentre, Paris, France, 2 MSF, Maputo, Mozambique, 3 MSF, Nairobi, Kenya, 4 Mbarara Univ of Sci and Tech, Mbarara, Uganda, 5 MSF, Geneva, Switzerland, 6 MSF, Paris, France, 7 Epicentre, Cape Town, South Africa, 8 MSF, Epicentre, Mbarara, Uganda 524 EFFECT OF OST AND PSYCHOTHERAPY ONHIV RISK AMONG HCV INFECTED INDIVIDUALS Zahid A. Butt 1 , Nabin Shrestha 1 , Naveed Z. Janjua 2 , for the The BC-HTC Team 1 Univ of British Columbia, Vancouver, British Columbia, Canada, 2 BC Cntr for Disease Control, Vancouver, British Columbia, Canada 522 HCV IN DEMOCRATIC REPUBLIC OF THE CONGO: Anne Loarec 1 , Lucas Molfino 2 , Kizito Walter 3 , Winnie Muyindike 4 , Valentina Carnimeo 1 , Isabelle Andrieux-Meyer 5 , Suna Balkan 6 , Yvonne Nzomukunda 3 , David Maman 7 , Juliet Mwanga-Amumpaire 8

Poster Sessions • Tuesday

CROI 2017 93